In humans, heterozygous loss-of-function variants in NSD1 increase skeletal growth in Sotos syndrome, whereas, in mice, homozygous loss of Nsd1 impairs skeletal growth, in part by regulating Sox9 expression in chondrocytes (27). This evidence concerns the gene NSD1 and Sotos syndrome.